Vasileios Tsatlidis
Overview
Explore the profile of Vasileios Tsatlidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tee S, Tsatlidis V, Razvi S
Clin Endocrinol (Oxf)
. 2023 Feb;
99(4):401-408.
PMID: 36843143
Objective: Glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in patients with type 2 diabetes and obesity leads to a significant reduction in serum thyrotropin (TSH) levels but it is unclear...
2.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, et al.
Health Technol Assess
. 2022 Oct;
26(39):1-100.
PMID: 36259684
Background: The mainstay of treatment for diabetic peripheral neuropathic pain is pharmacotherapy, but the current National Institute for Health and Care Excellence guideline is not based on robust evidence, as...
3.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, et al.
Lancet
. 2022 Aug;
400(10353):680-690.
PMID: 36007534
Background: Diabetic peripheral neuropathic pain (DPNP) is common and often distressing. Most guidelines recommend amitriptyline, duloxetine, pregabalin, or gabapentin as initial analgesic treatment for DPNP, but there is little comparative...
4.
Javaid U, Kennedy D, Addison C, Tsatlidis V, Razvi S
Eur J Endocrinol
. 2022 Mar;
186(5):553-560.
PMID: 35275844
Objective: To assess the rationale and frequency of thyroid function testing and to analyse factors that influence serum thyrotropin (TSH) levels. Patients, Design And Main Outcome Measures: Serum TSH levels...
5.
Abdalaziz A, Vanka R, Bartholomew P, Vennart N, Vernazza J, Stewart K, et al.
Clin Endocrinol (Oxf)
. 2022 Mar;
97(1):100-105.
PMID: 35244288
Objective: To evaluate the prevalence and clinical significance of nonuniform technetium ( Tc) uptake among patients with Graves' disease (GD). Design, Patients And Measurements: Patients with GD, referred between July...
6.
Bano A, Gan E, Addison C, Narayanan K, Weaver J, Tsatlidis V, et al.
J Clin Endocrinol Metab
. 2018 Dec;
104(5):1378-1385.
PMID: 30517711
Context: Thyrotropin receptor antibodies (TRAbs) play a crucial role in the pathogenesis of Graves disease (GD). However, factors that influence the association of TRAbs with thyroid hormones and relapse risk...
7.
Zhyzhneuskaya S, Addison C, Tsatlidis V, Weaver J, Razvi S
Thyroid
. 2016 Apr;
26(6):765-9.
PMID: 27090092
Background: There is little information regarding the natural history of subclinical hyperthyroidism (SH) due to Graves' disease (GD). Methods: A prospective analysis was conducted of patients with SH due to...